Evidence Hub

Infective endocarditis caused by Escherichia coli O25b:H4-B2-ST131: A case report providing genotypic, phenotypic, and phylogenetic insights

Flórez-Navas PC, Josa D, Silva-Monsalve E, Ballesteros N, Castañeda S, Muñoz M, Robayo-Amortegui H, Buitrago-Bernal R et al.

The Journal of international medical research, 2025

2 citations

Abstract

An unusual case of infective endocarditis caused by a strain of extended-spectrum β-lactamase Escherichia coli O25b:H4-B2-ST131 originating from a urinary tract infection is described. This paper has thoroughly analyzed the distinctive genotypic, phenotypic, and phylogenetic elements of the strain, correlating them with the patient's severe clinical presentation, diagnostic course, and successful outcome achieved through intensive antibiotic and surgical management, culminating in mitral valve replacement. Additionally, we proposed a hypothesis regarding the pathophysiology of infective endocarditis caused by extended-spectrum β-lactamase Escherichia coli, based on genotypic and phylogenetic analyses. A host-related explanatory approach was also assessed. Understanding the importance of early and real-time genotyping and molecular characterization of an Escherichia coli strain with a potential mechanism for developing infective endocarditis may help guide future clinical practice.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free